Home » Modena announces that its vaccine is effective against Delta virus, stock price jumps to new highs | A hot stock

Modena announces that its vaccine is effective against Delta virus, stock price jumps to new highs | A hot stock

by admin

On June 29, local time, vaccine manufacturer Modena announced a research report that showed that the company’s new crown vaccine can produce neutralizing antibodies against new mutant viruses including Delta mutations. In addition, research data also shows that the antibodies produced by the vaccine are more effective against the delta variant than against the Beta variant, which was first discovered in Africa.

Although the study did not directly determine how effective the Modena vaccine is against delta variants, it can prove that the neutralizing antibodies it produces are sufficient for prevention.

On June 29, India included Modena’s new crown vaccine on the country’s emergency use list to increase the country’s vaccination efforts. On the same day, Modena’s stock hit a record high in intraday trading, with a maximum increase of nearly 7%. As of the close of the day, the stock rose more than 5%.

The delta mutant virus was first discovered in India. At present, the virus has spread to at least 92 countries around the world, and it may become the major new coronavirus mutant worldwide.

Modena announced that its vaccine is effective against the Delta virus and its stock price jumped to a new high. Click on the video to see what it is!

This content is original by CBN, and the copyright belongs to CBN. Without the written authorization of CBN, it may not be used in any way, including reprinting, extracting, copying or creating mirror images. CBN reserves the right to pursue the legal liability of the infringer. If you need to obtain authorization, please contact the copyright department of CBN: 021-22002972 or 021-22002335; [email protected].

.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy